Potentially, through inhibition of cardiac fibrosis and cardiomyocyte hypertrophy, overexpressions of FTO could lead to cardiac functional benefits in diabetic cardiomyopathy mice [37]. The gene discussed is FTO; the disease is diabetic cardiomyopathy.